Capital Flow Monitor · Sponsors · CIK 1730728
ZETAGEN THERAPEUTICS, INC.
841 EAST FAYETTE STREET, SYRACUSE, NY, 13210 · 315-475-2200
Pharmaceuticals · Corporation· inc. DELAWARE true
Fit score
—
Offering
$13.0M
Sold
$12.9M
% sold
99.3%
Investors
35
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-11-12 | D/A ·current | 506(b) | $13.0M | $12.9M | 99.3% | 35 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Nikhil Thakur, MD — Executive Officer / Director, Andover, MA
-
Peter B. Finn — Executive Officer, Boston, MA
1 other raise
- CeleCor Therapeutics, Inc. $11.9M of $15.0M · 79.0%
- Joe C Loy — Executive Officer / Director, Weatherford, TX
- Donald Brown — Director, Hopkinton, MA
- Ashok Kaveeshwar — Director, Bethesda, MD
-
Richard Warburg — Director, Bethesda, MD
2 other raises
- Kaida BioPharma Inc. $1.6M of $4.1M · 39.0%
- eLux Medical, Inc. $1.3M of $4.0M · 31.9%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.